The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Agilent Technologies is attractively priced right now, ...
Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...
According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
Agilent Technologies (A) and Danaher (DHR) screen as potential buyers of Qiagen (QGEN) after a report that the European molecular testing firm is weighing its options after takeover interest. "QGEN ...
According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow ...
According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results